Roy A. Ehrnström
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Oncology top 10%
Papers in
-
- Breast Cancer Treatment Studies 4
- Oncology 6
- Co-authors
- Anita Sjölander (8 shared papers)Anders S Bjartell (4 shared papers)David Ulmert (3 shared papers)Tommy Andersson (7 shared papers)Anders Edsjö (2 shared papers)Yvonne Ceder (2 shared papers)Zandra Hagman (1 shared paper)Hans G. Lilja (1 shared paper)
- Journals
- International Journal of Cancer (12 papers)PLoS ONE (3 papers)Cancer Epidemiology Biomarkers & Prevention (2 papers)European Urology (2 papers)Cancer Research (2 papers)
- Partner nations
- SwedenFranceNetherlands
In The Last Decade
Roy A. Ehrnström
36 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 64
- Cancer Research 188
- Oncology 181
- Biochemistry 52
- Pulmonary and Respiratory Medicine 184
- Pharmacology 85
Countries citing papers authored by Roy A. Ehrnström
This map shows the geographic impact of Roy A. Ehrnström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy A. Ehrnström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy A. Ehrnström more than expected).
Fields of papers citing papers by Roy A. Ehrnström
This network shows the impact of papers produced by Roy A. Ehrnström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy A. Ehrnström. The network helps show where Roy A. Ehrnström may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy A. Ehrnström, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 139 | |
| 2 | 2012 | 118 | |
| 3 | 2016 | 91 | |
| 4 | 2010 | 64 | |
| 5 | 2011 | 59 | |
| 6 | 2011 | 59 | |
| 7 | 2010 | 51 | |
| 8 | 2016 | 49 | |
| 9 | 2011 | 46 | |
| 10 | 2007 | 41 | |
| 11 | 2009 | 41 | |
| 12 | 2012 | 41 | |
| 13 | 2011 | 40 | |
| 14 | 2013 | 38 | |
| 15 | 2020 | 28 | |
| 16 | 2009 | 27 | |
| 17 | 2012 | 27 | |
| 18 | 2017 | 27 | |
| 19 | 2013 | 24 | |
| 20 | 2014 | 24 |
About Roy A. Ehrnström
Roy A. Ehrnström is a scholar working on Cancer Research, Oncology, Public Health, Environmental and Occupational Health, Biochemistry and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nutritional Studies and Diet (8 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (4 papers), Inflammatory mediators and NSAID effects (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Prostate Cancer Treatment and Research (3 papers) and Sphingolipid Metabolism and Signaling (2 papers). The work is most often cited by research in Cancer Research (188 citations), Oncology (181 citations), Biochemistry (52 citations), Pulmonary and Respiratory Medicine (184 citations) and Pharmacology (85 citations). Roy A. Ehrnström has collaborated with scholars based in Sweden, France and Netherlands. Frequent co-authors include Anita Sjölander, Anders S Bjartell, David Ulmert, Tommy Andersson, Anders Edsjö, Yvonne Ceder, Zandra Hagman, Hans G. Lilja, Olivia Larne and Karin Jirström. Their work appears in journals such as International Journal of Cancer, PLoS ONE, Cancer Epidemiology Biomarkers & Prevention, European Urology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.